Caio Max S. Rocha Lima
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Epidemiology
- Cancer Research
- Co-authors
- Mark R. GreenJames E. HerndonMichael P. KostyGerald H. ClamonLaura ShoemakerUmesh K. AroraAnelisa K. CoutinhoBarbara A. Centeno
- Topics
- Pancreatic and Hepatic Oncology Research (14 papers)Cancer therapeutics and mechanisms (12 papers)Cancer Treatment and Pharmacology (9 papers)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Caio Max S. Rocha Lima
38 papers receiving 717 citations
Peers
Comparison fields: 5 of 73
- Oncology 537
- Pulmonary and Respiratory Medicine 253
- Molecular Biology 204
- Epidemiology 156
- Cancer Research 114
Countries citing papers authored by Caio Max S. Rocha Lima
This map shows the geographic impact of Caio Max S. Rocha Lima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caio Max S. Rocha Lima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caio Max S. Rocha Lima more than expected).
Fields of papers citing papers by Caio Max S. Rocha Lima
This network shows the impact of papers produced by Caio Max S. Rocha Lima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caio Max S. Rocha Lima. The network helps show where Caio Max S. Rocha Lima may publish in the future.
Co-authorship network of co-authors of Caio Max S. Rocha Lima
This figure shows the co-authorship network connecting the top 25 collaborators of Caio Max S. Rocha Lima. A scholar is included among the top collaborators of Caio Max S. Rocha Lima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caio Max S. Rocha Lima. Caio Max S. Rocha Lima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 21 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer. | 14 |
| 6 | 59 | |
| 7 | 0 | |
| 8 | 11 | |
| 9 | 32 | |
| 10 | 20 | |
| 11 | 13 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | 48 | |
| 15 | 4 | |
| 16 | 27 | |
| 17 | 122 | |
| 18 | Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer. | 3 |
| 19 | 118 | |
| 20 | Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer. | 16 |
About Caio Max S. Rocha Lima
Caio Max S. Rocha Lima is a scholar working on Oncology, Biotechnology and Hepatology, having authored 39 papers that have together received 735 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer therapeutics and mechanisms (12 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (537 citations), Pulmonary and Respiratory Medicine (253 citations) and Cancer Research (114 citations). Caio Max S. Rocha Lima has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Mark R. Green, James E. Herndon, Michael P. Kosty, Gerald H. Clamon, Laura Shoemaker, Umesh K. Arora, Anelisa K. Coutinho, Barbara A. Centeno, Ahmad R. Safa and M. R. Green. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.